Novartis turns cell therapy skill into contract manufacturing deal
Bio Pharma Dive
MARCH 10, 2022
In an unusual arrangement, the Swiss pharma will make Carisma Therapeutics' experimental cell therapy at its Morris Plains factory, part of its plans to build up a CMO business.
Let's personalize your content